БОШ МИЯ ИНСУЛЬТЛАРИНИНГ ХАВФ ОМИЛЛАРИ
Abstract
Эпидемиологик тадқиқотлар натижасида инсультга олиб келувчи хавф омилларининг кенг спектри аниқланган бўлиб, булар инсультнинг бирламчи ва иккиламчи профилактикасида жуда муҳим ҳисобланади. Инсульт хавф омилларини иккита гуруҳга ажратиш мумкин: ўзгарадиган хавф омиллари ва ўзгармайдиган хавф омиллари. Ўзгарадиган хавф омилларига гипертония, қандли диабет, қонда холестерин миқдорининг юқорилиги, юрак қон томир касалликлари, гиподинамия, бўлмачалар фибриляцияси, чекиш ва спиртли ичимликларни истеъмол қилиш кабилар киради [41, 59]. Ўзгармайдиган хавф омиллари унчалик кўп эмас, буларга ёш ва жинс, ирқий мансублик ва ирсият кабилар киради [12, 52].
References
1. Armaganijan L. et al. New pharmacotherapy for stroke prevention in atrial fibrillation: update 2010 //Advances in therapy. – 2009. – Т. 26. – С. 1058-1071.
2. Asdaghi N. et al. Sex disparities in ischemic stroke care: FL-PR CReSD study (Florida–Puerto Rico Collaboration to Reduce Stroke Disparities) //Stroke. – 2016. – Т. 47. – №. 10. – С. 2618-2626.
3. Béjot Y., Delpont B., Giroud M. Rising stroke incidence in young adults: more epidemiological evidence, more questions to be answered //Journal of the American Heart Association. – 2016. – Т. 5. – №. 5. – С. e003661.
4. Belt G. S. Global Stroke Belt //Stroke. – 2015. – Т. 46. – С. 3564-3570.
5. Boot E. et al. Ischaemic stroke in young adults: a global perspective //Journal of Neurology, Neurosurgery & Psychiatry. – 2020. – Т. 91. – №. 4. – С. 411-417.
6. Cabral N. L. et al. Increase of stroke incidence in young adults in a middle-income country: a 10-year population-based study //Stroke. – 2017. – Т. 48. – №. 11. – С. 2925-2930.
7. Carey R. M., Whelton P. K., 2017 ACC/AHA Hypertension Guideline Writing Committee*. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline //Annals of internal medicine. – 2018. – Т. 168. – №. 5. – С. 351-358.
8. Dorner T. E., Rieder A. Obesity paradox in elderly patients with cardiovascular diseases //International journal of cardiology. – 2012. – Т. 155. – №. 1. – С. 56-65.
9. Dulicek P. et al. Analysis of risk factors of stroke and venous thromboembolism in females with oral contraceptives use //Clinical and Applied Thrombosis/Hemostasis. – 2018. – Т. 24. – №. 5. – С. 797-802.
10. Ekker M. S. et al. Stroke incidence in young adults according to age, subtype, sex, and time trends //Neurology. – 2019. – Т. 92. – №. 21. – С. e2444-e2454.
11. Everett B., Zajacova A. Gender differences in hypertension and hypertension awareness among young adults //Biodemography and social biology. – 2015. – Т. 61. – №. 1. – С. 1-17.
12. Fredwall M. et al. Gender differences in exclusion criteria for recombinant tissue-type plasminogen activator //Journal of Stroke and Cerebrovascular Diseases. – 2016. – Т. 25. – №. 11. – С. 2569-2574.
13. Goldstein L. B. et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association //Stroke. – 2011. – Т. 42. – №. 2. – С. 517-584.
14. Goto S. et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis //American heart journal. – 2008. – Т. 156. – №. 5. – С. 855-863. e2.
15. Gupta R., Wood D. A. Primary prevention of ischaemic heart disease: populations, individuals, and health professionals //The Lancet. – 2019. – Т. 394. – №. 10199. – С. 685-696.
16. Hosomi N. et al. Desirable low-density lipoprotein cholesterol levels for preventing stroke recurrence: a post hoc analysis of the J-STARS study (Japan statin treatment against recurrent stroke) //Stroke. – 2018. – Т. 49. – №. 4. – С. 865-871.
17. Hosomi N. et al. Pravastatin reduces the risk of atherothrombotic stroke when administered within six months of an initial stroke event //Journal of Atherosclerosis and Thrombosis. – 2018. – Т. 25. – №. 3. – С. 262-268.
18. HPS3/TIMI55–Reveal Collaborative Group. Effects of anacetrapib in patients with atherosclerotic vascular disease //New England Journal of Medicine. – 2017. – Т. 377. – №. 13. – С. 1217-1227.
19. Hudayberganov N. Y., Jabbarov M. T., Matyoqubov M. O. THE ROLE AND SIGNIFICANCE OF TRANSIENT CEREBRAL CIRCULATION DISORDERS IN THE DEVELOPMENT OF CEREBRAL STROKES IN EMERGENCY NEUROLOGY //ACTUAL PROBLEMS OF MODERN SCIENCE, EDUCATION AND TRAINING IN THE REGION. – 2017. – Т. 2. – С. 131.
20. Husain M. J. et al. Access to cardiovascular disease and hypertension medicines in developing countries: an analysis of essential medicine lists, price, availability, and affordability //Journal of the American Heart Association. – 2020. – Т. 9. – №. 9. – С. e015302.
21. Jiang L. et al. Translating the diabetes prevention program into American Indian and Alaska native communities: results from the special diabetes program for Indians diabetes prevention demonstration project //Diabetes care. – 2013. – Т. 36. – №. 7. – С. 2027-2034.
22. Johnson C. O. et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 //The Lancet Neurology. – 2019. – Т. 18. – №. 5. – С. 439-458.
23. Johnson W. et al. Stroke: a global response is needed //Bulletin of the World Health Organization. – 2016. – Т. 94. – №. 9. – С. 634.
24. Jousilahti P. et al. 40-year CHD mortality trends and the role of risk factors in mortality decline: the North Karelia project experience //Global heart. – 2016. – Т. 11. – №. 2. – С. 207-212.
25. Kilichev I. A. et al. BRAIN STROKES IN ECOLOGICALLY UNFAVORABLE AREAS OF THE ARAL SEA REGION //Schizophr. Bull. – 2013. – Т. 3. – С. 413-430.
26. Kilichev I. A. et al. Register of stroke in the desert-steppe zones of Uzbekistan //BIO Web of Conferences. – EDP Sciences, 2023. – Т. 65. – С. 04002.
27. Kim Y. D., Jung Y. H., Saposnik G. Traditional risk factors for stroke in East Asia //Journal of Stroke. – 2016. – Т. 18. – №. 3. – С. 273.
28. Lavie C. J. et al. Healthy weight and obesity prevention: JACC health promotion series //Journal of the American College of Cardiology. – 2018. – Т. 72. – №. 13. – С. 1506-1531.
29. Lawson T. R. et al. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: outcomes associated with ambulation //Restorative neurology and neuroscience. – 2015. – Т. 33. – №. 3. – С. 301-308.
30. Leon D. A. et al. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? //International journal of epidemiology. – 2010. – Т. 39. – №. 5. – С. 1279-1290.
31. Li B. et al. Sex differences in outcomes and associated risk factors after acute ischemic stroke in elderly patients: a prospective follow-up study //Journal of Stroke and Cerebrovascular Diseases. – 2015. – Т. 24. – №. 10. – С. 2277-2284.
32. Li F. et al. Oral contraceptive use and increased risk of stroke: A dose-response meta-analysis of observational studies. Front Neurol. 2019;(10): 993 [Электронный ресурс].
33. Marks J. et al. Molecular-genetics aspects of migraine //International scientific review. – 2016. – №. 4 (14). – С. 212-215.
34. Mensah G. A. et al. Decline in cardiovascular mortality: possible causes and implications //Circulation research. – 2017. – Т. 120. – №. 2. – С. 366-380.
35. Mensah G. A., Roth G. A., Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond //Journal of the American College of Cardiology. – 2019. – Т. 74. – №. 20. – С. 2529-2532.
36. Mitchell A. B. et al. Obesity increases risk of ischemic stroke in young adults //Stroke. – 2015. – Т. 46. – №. 6. – С. 1690-1692.
37. Muntner P. et al. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018 //Jama. – 2020. – Т. 324. – №. 12. – С. 1190-1200.
38. Nam K. W. et al. Cerebral white matter hyperintensity is associated with intracranial atherosclerosis in a healthy population //Atherosclerosis. – 2017. – Т. 265. – С. 179-183.
39. Nathaniel T. I. et al. Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke //Brain injury. – 2016. – Т. 30. – №. 10. – С. 1261-1265.
40. Ng M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 //The lancet. – 2014. – Т. 384. – №. 9945. – С. 766-781.
41. O'Donnell M. J. et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study //The lancet. – 2016. – Т. 388. – №. 10046. – С. 761-775.
42. Rehm J., Taylor B., Patra J. Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002 //Addiction. – 2006. – Т. 101. – №. 8. – С. 1086-1095.
43. Savitz S. I. et al. Stem cells as an emerging paradigm in stroke 3 //Stroke. – 2014.
44. Shahreyar M. et al. Hyperlipidemia: Management with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors //The Journal of the American Board of Family Medicine. – 2018. – Т. 31. – №. 4. – С. 628-634.
45. Sirimarco G. et al. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients //Stroke. – 2014.
46. Sliwa K. Heart failure can affect everyone: the ESC Geoffrey Rose lecture. Eur HeartJ41 (12): 1298–1306 [Электронный ресурс].
47. Stanaway J. D. et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 //The Lancet. – 2018. – Т. 392. – №. 10159. – С. 1923-1994.
48. Syamlal G., Mazurek J. M., Dube S. R. Gender differences in smoking among US working adults //American journal of preventive medicine. – 2014. – Т. 47. – №. 4. – С. 467-475.
49. TRENDS O. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 //Jama. – 2012. – Т. 307. – №. 5. – С. 491-497.
50. Wapshott T. et al. Investigation of gender differences and exclusive criteria in a diabetic acute ischemic stroke population treated with recombinant tissue-type plasminogen activator (rtPA) //Journal of Vascular and Interventional Neurology. – 2017. – Т. 9. – №. 6. – С. 26.
51. Williamson J. D. et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial //Jama. – 2019. – Т. 321. – №. 6. – С. 553-561.
52. Winovich D. T. et al. Factors associated with ischemic stroke survival and recovery in older adults //Stroke. – 2017. – Т. 48. – №. 7. – С. 1818-1826.
53. Zeng Y. et al. Knowledge of stroke warning signs and risk factors among patients with previous stroke or TIA in China //Journal of clinical nursing. – 2012. – Т. 21. – №. 19pt20. – С. 2886-2895.
54. Zimmerman M. S. et al. Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 //The Lancet Child & Adolescent Health. – 2020. – Т. 4. – №. 3. – С. 185-200.
55. Аксельрод А. С., Сыркин А. Л. Нарушения со стороны сердечно-сосудистой системы и их коррекция у пациентов с алкогольной зависимостью, прекративших употреблять алкоголь //Эффективная фармакотерапия. – 2013. – №. 49. – С. 22-33.
56. Бобожанов У. А., Киличев И. А. STRUCTURE OF EPILEPTIC VESSELS IN CHILDREN RESIDING IN THE AREAL REGION AREA //Новый день в медицине. – 2019. – №. 3. – С. 70-72.
57. Бобожанов У. А., Садикова Г. К. CLINICAL AND DIAGNOSTIC CHARACTERISTICS OF CHILDREN'S EPILEPSY LIVING IN THE ARAL SEA REGION.
58. Болотова М. Н. и др. Синдром обструктивного апноэ сна как независимый фактор риска развития сердечнососудистых осложнений //Кардиоваскулярная терапия и профилактика. – 2009. – Т. 8. – №. 5. – С. 103-112.
59. Каерова Е. В. и др. Анализ основных факторов риска развития инсульта //Современные проблемы науки и образования. – 2017. – №. 6. – С. 133-133.
60. Киличев И. А., Адамбаев З. И., Матёкубов М. О. ДИНАМИКА НЕКОТОРЫХ ЭПИДЕМИОЛОГИЧЕСКИХ ПОКАЗАТЕЛЕЙ ИНСУЛЬТА В ПУСТЫННО-СТЕПНЫХ ЗОНАХ УЗБЕКИСТАНА ЗА ПЕРИОД НЕЗАВИСИМОСТИ РЕСПУБЛИКИ //Медицинские новости. – 2022. – №. 1 (328). – С. 76-78.
61. Орлова А. С. и др. Осведомленность населения о факторах риска и основных симптомах инсульта (обзор литературы) //Профилактическая медицина. – 2015. – Т. 18. – №. 6. – С. 91-96.
62. Остроумова О. Д. Алкоголь-друг или враг? //Эффективная фармакотерапия. – 2013. – Т. 49. – С. 8-12.
63. Худайберганов Н. Ю., Жаббаров М. Т., Матёкубов М. О. Неврологическая семиотика у больных железодефицитной анемией тяжелой степени //Национальный журнал неврологии. – 2017. – Т. 1. – №. S11. – С. 54-56.
